Faculty Bibliography

Subjects. The authors studied 213 pregnant or postpartum young women, ages 12 to 19 years (mean age, 16.7 ± 1.4), who were consecutively e nrolled from the School for Pregnant and Parenting Teens in central Harlem, New York, NY; 60% of them were African American and 39% were Hispanic. Exposure. The primary exposure was whether the subjects enrolled in the study during pregnancy or postpartum; this exposure was a surrogate for periodontal treatment during pregnancy, because all subjects received periodontal treatment after enrollment. The subjects were exposed to a single session of treatment including oral hygiene instruction, full mouth debridement with hand or ultrasonic instruments, polishing with a fluoridated paste, and dental sealants as needed. The 107 subjects enrolled during pregnancy received the treatment before delivery, predominantly in the second trimester (considered exposed), and the 106 enrolled postpartum received the treatment within 3 months after delivery (considered unexposed). Other exposures included plaque index, percentage of sites with bleeding on probing, percentage of sites with calculus, probing depth (mm), and average microbial load for specific bacteria between mothers of healthy and pre-term low birth weight babies. Main Outcome Measure. The incidence of pre-term delivery or delivery of low-birth weight infants in either group. Main Results. Significantly elevated levels of the gram-negative anaerobes, Bacteroides forsythus and Campylobacter rectus, were observed in subgingival plaque samples of the subjects enrolled postpartum who delivered PLBW infants, compared with those enrolled postpartum who delivered healthy infants. The administration of periodontal treatment to pregnant subjects before delivery had no significant effect on the incidence of PLBW infants (10 PLBW cases out of 74 [13.5%] for those receiving treatment versus 17 PLBW cases out of 90 [18.9%] not receiving treatment).

Recent evidence suggests that periodontal disease may play an etiologic role in the pathogenesis of several systemic illnesses, such as cardiovascular disease and preterm birth. This article reviews proposed mechanisms for such associations and outlines studies currently underway aimed at clarifying this issue. Results from this line of research may fundamentally change the way we approach our periodontitis patients.

BACKGROUND: A specific composite genotype of the polymorphic interleukin-1 (IL-1) gene cluster has recently been associated with severe periodontitis. One polymorphism of the composite periodontitis-associated genotype (PAG) has been functionally linked with expression of high levels of IL-1. The purpose of this study was to test whether gingival crevicular fluid (GCF) levels of IL-1beta and tumor necrosis factor-alpha (TNFalpha), and gingival tissue levels of IL-1alpha, IL-1beta, and TNFalpha correlate with PAG, and to examine the effect of conservative periodontal therapy on these levels. METHODS: Twenty-two adults with moderate to advanced periodontal disease were enrolled. Polymerase chain reaction amplification and restriction enzymes were used to identify specific polymorphisms from peripheral blood samples. GCF samples were collected at baseline and 3 weeks following conservative treatment and analyzed by ELISA for IL-1beta and TNFalpha. An interproximal gingival biopsy was collected at baseline and follow-up and analyzed for IL-1alpha, IL-1beta, and TNFalpha by ELISA. RESULTS: The genotyping identified 7 as PAG(+) and 15 as PAG(-). The 2 groups were comparable in terms of existing periodontitis and age. In shallow sites (<4 mm), total IL-1beta in GCF was 2.5 times higher for PAG(+) patients prior to treatment (P=0.03), and 2.2 times higher after treatment (P=0.04), while differences were less apparent in deeper sites. Following treatment, a reduction in IL-1beta concentration in GCF was seen for PAG(-) but not for PAG(+) patients. While not statistically significant, a trend was observed in mean tissue levels of IL-1beta which were 3.6 times higher in PAG(+) versus PAG(-) patients (P=0.09). CONCLUSIONS: These data suggest that PAG(+) patients may demonstrate phenotypic differences as indicated by elevated levels of IL-1beta in GCF.

Our understanding of the etiology and pathogenesis of periodontal diseases has grown in the recent past, and new findings have led to advances in patient management. This article summarizes important new knowledge and offers a description of traditional and novel diagnostic approaches. These include clinical and radiographic assessments of the periodontal tissues, evaluation of the microbial challenge and the host response, and certain elements of the host genotype that may confer susceptibility to destructive periodontal diseases.

Treatment of partial and total edentulism with submerged and nonsubmerged dental implants which follows the concept of osseointegration has become an accepted treatment modality. With compromised implant sites, practitioners have begun to combine one-stage implants with established techniques including guided bone regeneration. However, the clinical evaluation of this technique is limited. Therefore, the purpose of this study was to evaluate osseointegration and bone regeneration around nonsubmerged or submerged implants placed directly into surgically created osseous defects with or without expanded polytetrafluoroethylene (ePTFE) membranes. A total of 24 implants were placed in the mandibles of 4 beagle dogs and randomly assigned to 1 of 3 treatment groups. In group A, nonsubmerged implants were placed into osseous defects and treated with a poncho style ePTFE membrane. These membranes had a hole punched into the center and were slipped over the nonsubmerged implants. In group B, nonsubmerged implants were placed into osseous defects without an ePTFE membrane. In group C, submerged implants were placed into osseous defects and covered with an ePTFE membrane. Histometric measurements of each treatment group were made to determine percent bone gain or loss along the implant surface. Although a number of membrane removals occurred during the healing period, histological analysis indicated osseous ingrowth and osseointegration around nonsubmerged and submerged implants. An overall comparison of the treatment groups with ANOVA revealed that there were no significant differences between treatment groups, P > or = 0.05. However, when the data were stratified into sites which retained or lost the ePTFE membrane, the percent of bone regeneration was reduced in group A. Therefore, it may be recommended that nonsubmerged implants be placed with a submerged or "semi-submerged" protocol when utilized in conjunction with ePTFE membranes.